Search Results | Cancer Research | American Association for Cancer Research

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Abstract CT502: Preliminary immunological monitoring of first-in-human immunotherapy-trio for advanced head and neck squamous cell carcinoma

Cancer Res (2022) 82 (12_Supplement): CT502.

DOI: https://doi.org/10.1158/1538-7445.AM2022-CT502

Published: 15 June 2022

View article

Journal Articles

Abstract OT1-18-04: A phase II study of dual immune checkpoint blockade (ICB) plus bicalutamide to enhance thymic T-cell production and immunotherapy response in metastatic breast cancer (MBC)

David B Page, Krystle L Collins, Brie Chun, Zhaoyu Sun, William L Redmond, Maritza Martel, Yaping Wu, Nicole Moxon, Staci L Mellinger, Walter J Urba, Tiffany A Traina, Ayca Gucalp

Cancer Res (2022) 82 (4_Supplement): OT1-18-04.

DOI: https://doi.org/10.1158/1538-7445.SABCS21-OT1-18-04

Published: 15 February 2022

View article

Journal Articles

Abstract P2-12-14: A pilot evaluation of cold-capping efficacy under real world conditions for the prevention of chemotherapy-induced alopecia in early stage breast cancer

Manaz Rezayee, Alison K Conlin, Janet Ruzich, Nicole Fredrich, Amanda Y Seino, Susan Mulligan, Tracy L Kelly, Julie Cramer, Walter J Urba, David B Page

Cancer Res (2020) 80 (4_Supplement): P2-12-14.

DOI: https://doi.org/10.1158/1538-7445.SABCS19-P2-12-14

Published: 15 February 2020

View article

Journal Articles

Abstract CT073: Immunomodulatory effects of nivolumab and ipilimumab in combination or nivolumab monotherapy in advanced melanoma patients: CheckMate 038

Antoni Ribas, Salvador Martín-Algarra, Shailender Bhatia, Wen-Jen Hwu, Craig L. Slingluff, William H. Sharfman, F. Stephen Hodi, Walter J. Urba, Jason J. Luke, John B. Haanen, Margaret K. Callahan, Jedd D. Wolchok, Scott D. Chasalow, Petra Ross-Macdonald, Tina C. Young, Anila Qureshi, Christine E. Horak

Cancer Res (2017) 77 (13_Supplement): CT073.

DOI: https://doi.org/10.1158/1538-7445.AM2017-CT073

Published: 01 July 2017

View article

Journal Articles

Abstract 2988: Immunogenomic analyses of tumor cells and microenvironment in patients with advanced melanoma before and after treatment with nivolumab

Cancer Res (2017) 77 (13_Supplement): 2988.

DOI: https://doi.org/10.1158/1538-7445.AM2017-2988

Published: 01 July 2017

View article

Journal Articles

Serum Immunoregulatory Proteins as Predictors of Overall Survival of Metastatic Melanoma Patients Treated with Ipilimumab

Yoshinobu Koguchi, Helena M. Hoen, Shelly A. Bambina, Michael D. Rynning, Richard K. Fuerstenberg, Brendan D. Curti, Walter J. Urba, Christina Milburn, Frances Rena Bahjat, Alan J. Korman, Keith S. Bahjat

Cancer Res (2015) 75 (23): 5084–5092.

DOI: https://doi.org/10.1158/0008-5472.CAN-15-2303

Published: 30 November 2015

View article

Includes: Supplementary data

Journal Articles

Abstract 2855: Immunomodulatory activity of nivolumab monotherapy in patients with advanced melanoma

Walter J. Urba, Salvador Martín-Algarra, Margaret Callahan, Jedd D. Wolchok, William H. Sharfman, Jeffrey A. Sosman, Shailender Bhatia, Wen-Jen Hwu, Thomas F. Gajewski, Craig L. Slingluff, Yun Shen, Christine E. Horak, F Stephen Hodi

Cancer Res (2015) 75 (15_Supplement): 2855.

DOI: https://doi.org/10.1158/1538-7445.AM2015-2855

Published: 01 August 2015

View article

Journal Articles

Abstract P5-01-12: Breast specific gamma imaging (BSGI) and breast magnetic resonance imaging (MRI): Comparison of sensitivity and specificity in women prior to breast biopsy with BIRADS 4 or 5 finding on mammography in a community setting

Alison K Conlin, Nicole Moxon, Helena Hoen, Christina Gougoutas-Fox, Maureen O Baxter, Amy Weinstein, Maritza Martel, Tracy L Kelly, Walter J Urba

Cancer Res (2015) 75 (9_Supplement): P5-01-12.

DOI: https://doi.org/10.1158/1538-7445.SABCS14-P5-01-12

Published: 01 May 2015

View article

Journal Articles

OX40 Is a Potent Immune-Stimulating Target in Late-Stage Cancer Patients

Cancer Res (2013) 73 (24): 7189–7198.

DOI: https://doi.org/10.1158/0008-5472.CAN-12-4174

Published: 16 December 2013

View article

Includes: Supplementary data

Journal Articles

Efficient Cross-presentation Depends on Autophagy in Tumor Cells

Yuhuan Li, Li-Xin Wang, Guojun Yang, Fang Hao, Walter J. Urba, Hong-Ming Hu

Cancer Res (2008) 68 (17): 6889–6895.

DOI: https://doi.org/10.1158/0008-5472.CAN-08-0161

Published: 28 August 2008

View article

Includes: Supplementary data

Journal Articles

Cyclophosphamide treatment and reconstitution with peripheral blood mononuclear cells does not reduce the frequency of circulating FoxP3 cells in vaccinated prostate cancer patients

Ilka Assmann, Daniel Haley, Tarsem Moudgil, Christian Poehlein, Hong-Ming Hu, Edwin Walker, Nathalie Sacks, Kristen Hege, Brendan Curti, Walter J. Urba, Bernard A. Fox

Cancer Res (2006) 66 (8_Supplement): 681.

Published: 15 April 2006

View article

Journal Articles

Interleukin-7-Dependent Expansion and Persistence of Melanoma-Specific T Cells in Lymphodepleted Mice Lead to Tumor Regression and Editing

Li-Xin Wang, Rui Li, Guojun Yang, May Lim, Aisling O'Hara, Yiwei Chu, Bernard A. Fox, Nicholas P. Restifo, Walter J. Urba, Hong-Ming Hu

Cancer Res (2005) 65 (22): 10569–10577.

DOI: https://doi.org/10.1158/0008-5472.CAN-05-2117

Published: 15 November 2005

View article

Journal Articles

Development of Antitumor Immune Responses in Reconstituted Lymphopenic Hosts

Hong-Ming Hu, Christian H. Poehlein, Walter J. Urba, Bernard A. Fox

Cancer Res (2002) 62 (14): 3914–3919.

Published: 15 July 2002

View article

Journal Articles

Interstitial Pressure of Subcutaneous Nodules in Melanoma and Lymphoma Patients: Changes during Treatment

Brendan D. Curti, Walter J. Urba, W. Gregory Alvord, John E. Janik, John W. Smith, II, Karen Madara, Dan L. Longo

Cancer Res (1993) 53 (10): 2204–2207.

Published: 01 May 1993

View article

Journal Articles

Polyinosinic-Polycytidylic Acid Complexed with Poly-l-lysine and Carboxymethylcellulose in Combination with Interleukin 2 in Patients with Cancer: Clinical and Immunological Effects¹

Cynthia H. Ewel, Walter J. Urba, William C. Kopp, John W. Smith, II, Ronald G. Steis, Jeffrey L. Rossio, Dan L. Longo, Mary Jane Jones, W. Gregory Alvord, Carl M. Pinsky, Joy M. Beveridge, Karen L. McNitt, Stephen P. Creekmore

Cancer Res (1992) 52 (11): 3005–3010.

Published: 01 June 1992

View article

Journal Articles

Anti-CD3 Monoclonal Antibody Treatment of Patients with CD3-Negative Tumors: A Phase IA/B Study

Walter J. Urba, Cynthia Ewel, William Kopp, John W. Smith, II, Ronald G. Steis, Jonathan D. Ashwell, Stephen P. Creekmore, Jeffrey Rossio, Mario Sznol, William Sharfman, Robert Fenton, John Janik, Thelma Watson, Joy Beveridge, Dan L. Longo

Cancer Res (1992) 52 (9): 2394–2401.

Published: 01 May 1992

View article

Journal Articles

Antitumor Effects of Interleukin 2 Liposomes and Anti-CD3-Stimulated T-Cells against Murine MCA-38 Hepatic Metastasis

Cynthia M. Loeffler, Jeffrey L. Platt, Peter M. Anderson, Emmanuel Katsanis, Juan B. Ochoa, Walter J. Urba, Dan L. Longo, Arnold S. Leonard, Augusto C. Ochoa

Cancer Res (1991) 51 (8): 2127–2132.

Published: 01 April 1991

View article

Journal Articles

Interleukin 2 and Lymphokine-activated Killer Cell Therapy: Analysis of a Bolus Interleukin 2 and a Continuous Infusion Interleukin 2 Regimen

Jeffrey W. Clark, John W. Smith, II, Ronald G. Steis, Walter J. Urba, Edward Crum, Robin Miller, John McKnight, JoAnn Beman, Henry C. Stevenson, Stephen Creekmore, Michael Stewart, Kevin Conlon, Mario Sznol, Peter Kremers, Paul Cohen, Dan L. Longo

Cancer Res (1990) 50 (22): 7343–7350.

Published: 01 November 1990

View article

Journal Articles

Phase I and Immunomodulatory Study of a Muramyl Peptide, Muramyl Tripeptide Phosphatidylethanolamine

Walter J. Urba, Lynn C. Hartmann, Dan L. Longo, Ronald G. Steis, John W. Smith, II, Igal Kedar, Stephen Creekmore, Mario Sznol, Kevin Conlon, William C. Kopp, Christoph Huber, Manfred Herold, W. Gregory Alvord, Sandra Snow, Jeffrey W. Clark

Cancer Res (1990) 50 (10): 2979–2986.

Published: 01 May 1990

View article

Journal Articles

Immunomodulatory Properties and Toxicity of Interleukin 2 in Patients with Cancer

Walter J. Urba, Ronald G. Steis, Dan L. Longo, William C. Kopp, Annette E. Maluish, Luisa Marcon, David L. Nelson, Henry C. Stevenson, Jeffrey W. Clark

Cancer Res (1990) 50 (1): 185–192.

Published: 01 January 1990

View article

NARROW

Abstract CT502: Preliminary immunological monitoring of first-in-human immunotherapy-trio for advanced head and neck squamous cell carcinoma

Abstract OT1-18-04: A phase II study of dual immune checkpoint blockade (ICB) plus bicalutamide to enhance thymic T-cell production and immunotherapy response in metastatic breast cancer (MBC)

Abstract P2-12-14: A pilot evaluation of cold-capping efficacy under real world conditions for the prevention of chemotherapy-induced alopecia in early stage breast cancer

Abstract CT073: Immunomodulatory effects of nivolumab and ipilimumab in combination or nivolumab monotherapy in advanced melanoma patients: CheckMate 038

Abstract 2988: Immunogenomic analyses of tumor cells and microenvironment in patients with advanced melanoma before and after treatment with nivolumab

Serum Immunoregulatory Proteins as Predictors of Overall Survival of Metastatic Melanoma Patients Treated with Ipilimumab

Abstract 2855: Immunomodulatory activity of nivolumab monotherapy in patients with advanced melanoma

Abstract P5-01-12: Breast specific gamma imaging (BSGI) and breast magnetic resonance imaging (MRI): Comparison of sensitivity and specificity in women prior to breast biopsy with BIRADS 4 or 5 finding on mammography in a community setting

OX40 Is a Potent Immune-Stimulating Target in Late-Stage Cancer Patients

Efficient Cross-presentation Depends on Autophagy in Tumor Cells

Cyclophosphamide treatment and reconstitution with peripheral blood mononuclear cells does not reduce the frequency of circulating FoxP3 cells in vaccinated prostate cancer patients

Interleukin-7-Dependent Expansion and Persistence of Melanoma-Specific T Cells in Lymphodepleted Mice Lead to Tumor Regression and Editing

Development of Antitumor Immune Responses in Reconstituted Lymphopenic Hosts

Interstitial Pressure of Subcutaneous Nodules in Melanoma and Lymphoma Patients: Changes during Treatment

Polyinosinic-Polycytidylic Acid Complexed with Poly-l-lysine and Carboxymethylcellulose in Combination with Interleukin 2 in Patients with Cancer: Clinical and Immunological Effects¹

Anti-CD3 Monoclonal Antibody Treatment of Patients with CD3-Negative Tumors: A Phase IA/B Study

Antitumor Effects of Interleukin 2 Liposomes and Anti-CD3-Stimulated T-Cells against Murine MCA-38 Hepatic Metastasis

Interleukin 2 and Lymphokine-activated Killer Cell Therapy: Analysis of a Bolus Interleukin 2 and a Continuous Infusion Interleukin 2 Regimen

Phase I and Immunomodulatory Study of a Muramyl Peptide, Muramyl Tripeptide Phosphatidylethanolamine

Immunomodulatory Properties and Toxicity of Interleukin 2 in Patients with Cancer

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only